Cytokinetics, Incorporated (CYTK)

Cytokinetics Revenue

Cytokinetics had revenue of $66.77M in the quarter ending June 30, 2025, with 26,714.86% growth. This brings the company's revenue in the last twelve months to $85.74M, up 2,635.74% year-over-year. In the year 2024, Cytokinetics had annual revenue of $18.47M with 145.34% growth.

• Revenue (ttm): $85.74M
• Revenue Growth: +2,635.74%
• P/S Ratio: 83.14
• Revenue / Employee: $172,165
• Employees: 498
• Market Cap: 7.20B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	18.47M	10.94M	145.34%
Dec 31, 2023	7.53M	-87.06M	-92.04%
Dec 31, 2022	94.59M	24.16M	34.30%
Dec 31, 2021	70.43M	14.60M	26.15%
Dec 31, 2020	55.83M	28.96M	107.79%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.